These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 23232696)
1. Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer. Danza K; Pilato B; Lacalamita R; Addati T; Giotta F; Bruno A; Paradiso A; Tommasi S Eur J Hum Genet; 2013 Aug; 21(8):824-30. PubMed ID: 23232696 [TBL] [Abstract][Full Text] [Related]
2. Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in co‑cultures of human endothelial and breast cancer cells. González-González A; González A; Alonso-González C; Menéndez-Menéndez J; Martínez-Campa C; Cos S Oncol Rep; 2018 Jan; 39(1):433-441. PubMed ID: 29115538 [TBL] [Abstract][Full Text] [Related]
3. Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma. Zhang ZL; Liu ZS; Sun Q World J Gastroenterol; 2006 Jul; 12(26):4241-5. PubMed ID: 16830384 [TBL] [Abstract][Full Text] [Related]
4. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer. Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239 [TBL] [Abstract][Full Text] [Related]
5. Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer. Szarvas T; Jäger T; Tötsch M; vom Dorp F; Kempkensteffen C; Kovalszky I; Romics I; Ergün S; Rübben H Clin Cancer Res; 2008 Dec; 14(24):8253-62. PubMed ID: 19088043 [TBL] [Abstract][Full Text] [Related]
6. Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling. Currie MJ; Gunningham SP; Han C; Scott PA; Robinson BA; Harris AL; Fox SB Clin Cancer Res; 2001 Apr; 7(4):918-27. PubMed ID: 11309342 [TBL] [Abstract][Full Text] [Related]
7. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia. Hou HA; Chou WC; Lin LI; Tang JL; Tseng MH; Huang CF; Yao M; Chen CY; Tsay W; Tien HF Leuk Res; 2008 Jun; 32(6):904-12. PubMed ID: 17904634 [TBL] [Abstract][Full Text] [Related]
8. VEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer. Saponaro C; Malfettone A; Ranieri G; Danza K; Simone G; Paradiso A; Mangia A PLoS One; 2013; 8(1):e53070. PubMed ID: 23326384 [TBL] [Abstract][Full Text] [Related]
9. Increased mRNA expression of VEGF within the hematoma and imbalance of angiopoietin-1 and -2 mRNA within the neomembranes of chronic subdural hematoma. Hohenstein A; Erber R; Schilling L; Weigel R J Neurotrauma; 2005 May; 22(5):518-28. PubMed ID: 15892598 [TBL] [Abstract][Full Text] [Related]
10. The temporal-spatial expression of VEGF, angiopoietins-1 and 2, and Tie-2 during tumor angiogenesis and their functional correlation with tumor neovascular architecture. Tse V; Xu L; Yung YC; Santarelli JG; Juan D; Fabel K; Silverberg G; Harsh G Neurol Res; 2003 Oct; 25(7):729-38. PubMed ID: 14579791 [TBL] [Abstract][Full Text] [Related]
11. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers. Zugazagoitia J; Pérez-Segura P; Manzano A; Blanco I; Vega A; Custodio A; Teulé A; Fachal L; Martínez B; González-Sarmiento R; Cruz-Hernández JJ; Chirivella I; Garcés V; Garre P; Romero A; Caldés T; Díaz-Rubio E; de la Hoya M Breast Cancer Res Treat; 2014 Nov; 148(2):415-21. PubMed ID: 25342642 [TBL] [Abstract][Full Text] [Related]
12. The contribution of dietary and plasma folate and cobalamin to levels of angiopoietin-1, angiopoietin-2 and Tie-2 receptors depend on vascular endothelial growth factor status of primary breast cancer patients. Pirouzpanah S; Varshosaz P; Fakhrjou A; Montazeri V Sci Rep; 2019 Oct; 9(1):14851. PubMed ID: 31619709 [TBL] [Abstract][Full Text] [Related]
13. Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system. Rizkalla B; Forbes JM; Cao Z; Boner G; Cooper ME J Hypertens; 2005 Jan; 23(1):153-64. PubMed ID: 15643138 [TBL] [Abstract][Full Text] [Related]
14. Expression of angiopoietic factors in normal and type-I diabetes human placenta: a pilot study. Janota J; Pomyje J; Toth D; Sosna O; Zivný J; Kuzel D; Stranák Z; Necas E; Zivný JH Eur J Obstet Gynecol Reprod Biol; 2003 Dec; 111(2):153-6. PubMed ID: 14597243 [TBL] [Abstract][Full Text] [Related]
15. Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women. Comen E; Davids M; Kirchhoff T; Hudis C; Offit K; Robson M Breast Cancer Res Treat; 2011 Aug; 129(1):185-90. PubMed ID: 21394499 [TBL] [Abstract][Full Text] [Related]
16. CCND1 and ZNF217 gene amplification is equally frequent in BRCA1 and BRCA2 associated and non-BRCA breast cancer. Plevova P; Cerna D; Balcar A; Foretova L; Zapletalova J; Silhanova E; Curik R; Dvorackova J Neoplasma; 2010; 57(4):325-32. PubMed ID: 20429623 [TBL] [Abstract][Full Text] [Related]
17. Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel-Lindau gene and hypoxia. Currie MJ; Gunningham SP; Turner K; Han C; Scott PA; Robinson BA; Chong W; Harris AL; Fox SB J Pathol; 2002 Dec; 198(4):502-10. PubMed ID: 12434420 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor and angiopoietin are required for prostate regeneration. Wang GM; Kovalenko B; Huang Y; Moscatelli D Prostate; 2007 Apr; 67(5):485-99. PubMed ID: 17221843 [TBL] [Abstract][Full Text] [Related]
19. Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: implication for angiogenesis. Moon WS; Park HS; Yu KH; Jang KY; Kang MJ; Park H; Tarnawski AS J Korean Med Sci; 2006 Apr; 21(2):272-8. PubMed ID: 16614513 [TBL] [Abstract][Full Text] [Related]
20. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers. Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]